Molecular Partners AG Cash Flow Reinvestment Rate
Molecular Partners AG cash flow reinvestment rate. Molecular Partners AG (MOLN) has a Cash Flow Reinvestment Rate of 0.57x as of March 2022, reinvesting CHF93.61 Million (capex CHF380.00K plus investments CHF-93.23 Million) from operating cash flow of CHF163.56 Million. Explore MOLN debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Molecular Partners AG (2015–2022)
Cash flow reinvestment rate of Molecular Partners AG from 2015 to 2022. Historical reinvestment intensity for Molecular Partners AG across 2 annual periods. Explore MOLN capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Molecular Partners AG Cash Flow Reinvestment Rate by Year (2015–2022)
Molecular Partners AG cash flow reinvestment rate by year from 2015 to 2022. Year-by-year capital reinvestment analysis for Molecular Partners AG. For the full cash flow conversion analysis, see Molecular Partners AG (MOLN) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.86x | CHF102.54 Million | CHF118.57 Million | CHF1.42 Million | ▲ +7.0% |
| 2015 | 0.81x | CHF21.41 Million | CHF26.50 Million | CHF1.39 Million | — |